Related Experiment Video
Updated: Feb 11, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
1.9K
Biologics and chronic obstructive pulmonary disease
1Respiratory Medicine Unit and Oxford Respiratory NIHR BRC, Nuffield Department of Medicine, Oxford, United Kingdom.
The Journal of Allergy and Clinical Immunology
|May 7, 2018
Summary
Targeting eosinophilic airway inflammation with anti-IL-5 biologics shows promise for chronic obstructive pulmonary disease (COPD) patients. Biomarker-directed therapy may improve future biologic development for COPD.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Airway inflammation is a hallmark of chronic obstructive pulmonary disease (COPD).
- Biological agents targeting specific inflammatory pathways are effective in other chronic inflammatory diseases.
- Understanding COPD inflammatory heterogeneity is crucial for targeted therapies.
Purpose of the Study:
- To explore the potential of biological agents in treating COPD.
- To investigate the role of targeting eosinophilic airway inflammation in COPD.
- To assess the efficacy of anti-IL-5 therapy in COPD patients.
Main Methods:
- Review of recent phase III clinical studies on anti-IL-5 therapy in COPD.
- Analysis of blood eosinophil counts as a predictive biomarker.
- Evaluation of exacerbation rates in treated COPD patients.
Main Results:
- Anti-IL-5 therapy demonstrated a ~20% reduction in COPD exacerbations.
- Therapeutic benefits were dependent on blood eosinophil counts.
- Clinical efficacy linked to an accessible biomarker was observed.
Conclusions:
- Targeting eosinophilic airway inflammation with anti-IL-5 is a viable therapeutic strategy for COPD.
- Biomarker-directed use of biologics offers a precision medicine approach for COPD.
- This success may serve as a model for future biologic development in COPD.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K